News
An experimental cannabis-based drug has successfully treated children with a rare form of severe epilepsy in a keenly anticipated clinical trial, more than doubling the value of its maker GW Pharmaceuticals.
Ben Hirschler, Reuters, Mar 14, 2016
Return to Home